Employment Law Now VI-121 - Top 5 Fall Things You Need To Know
6 Key Takeaways | Whistleblower Programs: How the U.S. Government Seeks to Create a Speak-Up Culture & Parts of the World Want One Too
Labor & Employment Symposium - Topics: Remote Work; Handling Leaves of Absence; Vaccination Incentives Under Wellness Programs
#WorkforceWednesday: OSHA ETS in Review, Texas Vaccine Mandate Ban, Health Premium Incentives - Employment Law This Week®
Susan Roberts on Creating a Compliance Program Book
Investing in Colombia: Nearshoring & Economic Incentives in Manufacturing, Technology, Infrastructure, and Energy Industries
Williams Mullen's Comeback Plan: North Carolina’s COVID-19 Job Retention Program
Drug Pricing Initiatives During the Trump Presidency
PODCAST: Wellness Program Compliance Update
FCPA Pilot Program
Day 20 - Compliance Leadership from the Bottom
Unfair and Unbalanced-Episode 18
Day 13 of One Month to Better Compliance Thru HR
Day 11 of One Month to Better Compliance Through HR-the Fair Process Doctrine
This Week in FCPA- Episode 52, for the week ending May 12, the Firing the Investigators Edition
Day 10 Of One Month to Better Compliance through HR-Sales Incentives and Compliance
Day 8 of One Month to Better Compliance Through HR-Using Compensation to Operationalize Compliance
Day 7 Of One Month To Better Compliance Through HR - Six Principles For Compliance Incentives
Day 6 of One Month to Better Compliance Through HR-Incentivizing Compliance
Ten Hallmarks of an Effective Compliance Program-Hallmark 6
In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs, the Trump administration has proposed a series of changes to the...more
January 18, 2019, CMS’s Center for Medicare and Medicaid Innovation (CMMI) announced a new payment model aimed at lowering drug prices in Medicare Part D, named the Part D Payment Modernization model (the Part D Model). In...more
On Feb. 9, 2018, the Trump Administration released a 30-page report analyzing domestic and global factors influencing drug pricing. The report by the Council of Economic Advisers (CEA) is expected to inform the HHS' Fiscal...more
CMS Announces Part D Enhanced Medication Therapy Management Model Demonstration – On September 28, 2015, CMS announced a Part D Enhanced Medication Therapy Management Model (Enhanced MTM Model) that is designed to assess...more